These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 32436062)
1. Intracellular localization of beta-catenin expression plays a possible prognostic role on the outcome of hepatoblastoma patients. Celtik U; Dokumcu Z; Divarci E; Guler E; Ataseven E; Nart D; Yilmaz F; Celik A; Ergün O Pediatr Surg Int; 2020 Jul; 36(7):817-825. PubMed ID: 32436062 [TBL] [Abstract][Full Text] [Related]
2. HGF/c-Met related activation of β-catenin in hepatoblastoma. Purcell R; Childs M; Maibach R; Miles C; Turner C; Zimmermann A; Sullivan M J Exp Clin Cancer Res; 2011 Oct; 30(1):96. PubMed ID: 21992464 [TBL] [Abstract][Full Text] [Related]
3. Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. Park WS; Oh RR; Park JY; Kim PJ; Shin MS; Lee JH; Kim HS; Lee SH; Kim SY; Park YG; An WG; Kim HS; Jang JJ; Yoo NJ; Lee JY J Pathol; 2001 Apr; 193(4):483-90. PubMed ID: 11276007 [TBL] [Abstract][Full Text] [Related]
4. A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma tumors. Dubbink HJ; Hollink IHIM; Avenca Valente C; Wang W; Liu P; Doukas M; van Noesel MM; Dinjens WNM; Wagner A; Smits R Pediatr Blood Cancer; 2018 Jun; 65(6):e26991. PubMed ID: 29446530 [TBL] [Abstract][Full Text] [Related]
5. beta-Catenin and met deregulation in childhood Hepatoblastomas. Ranganathan S; Tan X; Monga SP Pediatr Dev Pathol; 2005; 8(4):435-47. PubMed ID: 16211454 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of beta-catenin in hepatoblastoma and its clinical significance. Archana B; D'Cruze L; Nazneen S; Thanka J; Scott JX J Cancer Res Ther; 2022; 18(3):677-680. PubMed ID: 35900540 [TBL] [Abstract][Full Text] [Related]
8. Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma. Wu JF; Chang HH; Lu MY; Jou ST; Chang KC; Ni YH; Chang MH J Biomed Sci; 2017 Aug; 24(1):62. PubMed ID: 28851352 [TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma. Sha YL; Liu S; Yan WW; Dong B Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31511432 [TBL] [Abstract][Full Text] [Related]
10. Elevated expression of Wnt antagonists is a common event in hepatoblastomas. Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610 [TBL] [Abstract][Full Text] [Related]
11. SOX7 modulates the progression of hepatoblastoma through the regulation of Wnt/β-catenin signaling pathway. Ge J; Zheng Q; Qu H; Zhao Z; Xu Y; Wang H; Gao H; Zhan J J Cancer Res Ther; 2022 Apr; 18(2):370-377. PubMed ID: 35645102 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors. Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411 [TBL] [Abstract][Full Text] [Related]
14. Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma. Jeng YM; Wu MZ; Mao TL; Chang MH; Hsu HC Cancer Lett; 2000 Apr; 152(1):45-51. PubMed ID: 10754205 [TBL] [Abstract][Full Text] [Related]
15. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling. Matsumoto S; Yamamichi T; Shinzawa K; Kasahara Y; Nojima S; Kodama T; Obika S; Takehara T; Morii E; Okuyama H; Kikuchi A Nat Commun; 2019 Aug; 10(1):3882. PubMed ID: 31462641 [TBL] [Abstract][Full Text] [Related]
16. β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice. Zhang W; Meyfeldt J; Wang H; Kulkarni S; Lu J; Mandel JA; Marburger B; Liu Y; Gorka JE; Ranganathan S; Prochownik EV J Biol Chem; 2019 Nov; 294(46):17524-17542. PubMed ID: 31597698 [TBL] [Abstract][Full Text] [Related]
17. Relationship of β-catenin and postchemotherapy histopathologic changes with overall survival in patients with hepatoblastoma. Gupta K; Rane S; Das A; Marwaha RK; Menon P; Rao KL J Pediatr Hematol Oncol; 2012 Nov; 34(8):e320-8. PubMed ID: 22735888 [TBL] [Abstract][Full Text] [Related]
18. Complementary roles of β-catenin and glutamine synthetase immunostaining in diagnosis of chemotherapy-treated and untreated hepatoblastoma. Huang WJ; Tsai JH; Jeng YM J Formos Med Assoc; 2017 Jul; 116(7):549-553. PubMed ID: 28277286 [TBL] [Abstract][Full Text] [Related]
19. Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model. Armengol C; Cairo S; Fabre M; Buendia MA Int J Biochem Cell Biol; 2011 Feb; 43(2):265-70. PubMed ID: 19646548 [TBL] [Abstract][Full Text] [Related]
20. Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam. Anna CH; Sills RC; Foley JF; Stockton PS; Ton TV; Devereux TR Cancer Res; 2000 Jun; 60(11):2864-8. PubMed ID: 10850429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]